ATE24478T1 - 3-hydroxybuttersaeure oder derer salze enthaltende pharmazeutische zusammensetzungen und als arzneimittel verwendbare, von 3hydroxybutters|ure abgeleitete verbindungen. - Google Patents

3-hydroxybuttersaeure oder derer salze enthaltende pharmazeutische zusammensetzungen und als arzneimittel verwendbare, von 3hydroxybutters|ure abgeleitete verbindungen.

Info

Publication number
ATE24478T1
ATE24478T1 AT83200228T AT83200228T ATE24478T1 AT E24478 T1 ATE24478 T1 AT E24478T1 AT 83200228 T AT83200228 T AT 83200228T AT 83200228 T AT83200228 T AT 83200228T AT E24478 T1 ATE24478 T1 AT E24478T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
compositions containing
ace
salts
compounds derived
Prior art date
Application number
AT83200228T
Other languages
English (en)
Inventor
Jacques Lammerant
Jaroslaw Kolanowski
Original Assignee
Solvay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay filed Critical Solvay
Application granted granted Critical
Publication of ATE24478T1 publication Critical patent/ATE24478T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT83200228T 1982-02-23 1983-02-15 3-hydroxybuttersaeure oder derer salze enthaltende pharmazeutische zusammensetzungen und als arzneimittel verwendbare, von 3hydroxybutters|ure abgeleitete verbindungen. ATE24478T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8203100A FR2521857B1 (fr) 1982-02-23 1982-02-23 Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee
EP83200228A EP0087192B1 (de) 1982-02-23 1983-02-15 3-Hydroxybuttersäure oder derer Salze enthaltende pharmazeutische Zusammensetzungen und als Arzneimittel verwendbare, von 3-Hydroxybuttersäure abgeleitete Verbindungen

Publications (1)

Publication Number Publication Date
ATE24478T1 true ATE24478T1 (de) 1987-01-15

Family

ID=9271331

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83200228T ATE24478T1 (de) 1982-02-23 1983-02-15 3-hydroxybuttersaeure oder derer salze enthaltende pharmazeutische zusammensetzungen und als arzneimittel verwendbare, von 3hydroxybutters|ure abgeleitete verbindungen.

Country Status (21)

Country Link
US (2) US4579955A (de)
EP (1) EP0087192B1 (de)
JP (1) JPS58201746A (de)
KR (1) KR910000143B1 (de)
AT (1) ATE24478T1 (de)
AU (2) AU560757B2 (de)
CA (1) CA1203242A (de)
DE (1) DE3368601D1 (de)
DK (1) DK163235C (de)
ES (2) ES519991A0 (de)
FI (1) FI79523C (de)
FR (1) FR2521857B1 (de)
GR (1) GR77934B (de)
IE (1) IE54561B1 (de)
IL (1) IL67965A0 (de)
MX (1) MX156855A (de)
NO (1) NO161909C (de)
NZ (1) NZ203279A (de)
PH (1) PH21561A (de)
PT (1) PT76267A (de)
ZA (1) ZA831019B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521857B1 (fr) * 1982-02-23 1985-10-31 Solvay Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee
USRE38604E1 (en) 1984-06-22 2004-09-28 Btg International Limited Fluid therapy with L-lactate and/or pyruvate anions
US6020007A (en) * 1984-06-22 2000-02-01 Btg International Limited Fluid therapy with l-lactate and/or pyruvate anions
US4777288A (en) * 1987-06-11 1988-10-11 Pfizer Inc. Process for preparing a 4,4-diphenylbutanoic acid derivative
BE1001209A3 (fr) * 1987-11-19 1989-08-22 Solvay Compositions pharmaceutiques contenant un derive de l'acide 3-hydroxybutanoique choisi parmi les oligomeres de cet acide et les esters de cet acide ou de ces oligomeres avec du 1,3-butanediol.
US5292774A (en) * 1988-07-26 1994-03-08 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Substitution fluid preparation comprising 3-hydroxy-butyric acid (β-hydroxybutric acid) and its salts
DE4113984C2 (de) * 1991-04-29 2002-05-08 Koehler Chemie Dr Franz Salze der 4-Hydroxy-Buttersäure
ES2051222B1 (es) * 1992-03-12 1995-02-16 Sanmiguel Gabriel Serrano Procedimiento de neutralizacion de acido alfa-hidroxietanoico.
JP4598203B2 (ja) 1995-12-01 2010-12-15 ビーティージー・インターナショナル・リミテッド 脳機能改善剤
US20090253781A1 (en) * 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
EP1017379B1 (de) * 1997-03-17 2014-12-10 BTG International Limited Therapeutische Zusammensetzungen enthaltend Ketonkörpern oder ihren Vorläufern
US6323237B1 (en) 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US6316038B1 (en) 1997-03-17 2001-11-13 Btg International Limited Therapeutic compositions
US6613356B1 (en) 2000-10-10 2003-09-02 Victor Vlahakos Weight loss medication and method
GB0420856D0 (en) * 2004-09-20 2004-10-20 Ketocytonyx Inc Cns modulators
US7947736B2 (en) * 2004-07-16 2011-05-24 Btg International Limited Oligomeric compounds
US7485743B2 (en) * 2004-07-20 2009-02-03 Btg International Limited Oligomeric ketone compounds
WO2006012490A2 (en) * 2004-07-23 2006-02-02 Ketocytonyx Inc. Ketogenic saccharides
WO2006034361A2 (en) * 2004-09-21 2006-03-30 Ketocytonyx Inc. Dopaminergic mimetics
WO2006098767A2 (en) * 2004-09-21 2006-09-21 Ketocytonyx Inc. Treatment of adhd
RU2302239C1 (ru) * 2006-07-14 2007-07-10 Михаил Владимирович Покровский Способ фармакологической коррекции ишемии конечности
JPWO2008053982A1 (ja) 2006-10-30 2010-02-25 株式会社オフテクス アレルギー治療用組成物
EP3659595A1 (de) 2012-11-05 2020-06-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Ketonkörper zum schutz von geweben vor beschädigung durch ionisierende strahlung
JP6875288B2 (ja) 2015-11-19 2021-05-19 協和発酵バイオ株式会社 3−ヒドロキシイソ吉草酸の一価カチオン塩の結晶および該結晶の製造方法
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US12109182B2 (en) 2016-04-19 2024-10-08 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US12496283B2 (en) 2016-04-19 2025-12-16 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US12329734B2 (en) 2017-12-19 2025-06-17 Axcess Global Sciences, Llc Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
JP6710098B2 (ja) * 2016-05-10 2020-06-17 大阪瓦斯株式会社 栄養剤組成物及び栄養補助食品
AU2017282515A1 (en) * 2016-06-24 2019-01-17 Otsuka Pharmaceutical Factory, Inc. Crystal of β-hydroxy β-methylbutyric acid amino acid salt and production method therefor
US12090129B2 (en) 2017-11-22 2024-09-17 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US12472200B2 (en) 2019-05-15 2025-11-18 Axcess Global Sciences, Llc Autobiotic compositions and method for promoting healthy gut microbiome
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance
US12167993B2 (en) 2019-06-21 2024-12-17 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
CN112341331B (zh) * 2019-08-07 2023-04-07 辽宁科硕营养科技股份有限公司 一种3-羟基丁酸盐及其制备方法与应用
US12186297B2 (en) 2020-08-26 2025-01-07 Axcess Global Sciences, Llc Compositions and methods for increasing lean-to-fat mass ratio
WO2024192165A1 (en) * 2023-03-14 2024-09-19 The Board Of Trustees Of The Leland Stanford Junior University N-beta-hydroxybutyryl-amino acids and related compositions and methods
WO2025056246A1 (en) * 2023-09-11 2025-03-20 Societe Des Produits Nestle S.A. Polymorphs and compositions comprising same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2101097A (en) * 1934-07-26 1937-12-07 Wm S Merrell Co Products for rendering the urine bacteriostatic
US2799684A (en) * 1954-06-18 1957-07-16 Food Chemical And Res Lab Inc Crystalline compounds of tryptophane and methods of manufacturing them
NL279760A (de) * 1961-06-17
US3830931A (en) * 1972-11-06 1974-08-20 Felice S De Carnitine and its use in the treatment of arrhythmia and impaired cardiac function
US3879537A (en) * 1973-09-04 1975-04-22 Scott Eugene J Van Treatment of ichthyosiform dermatoses
DE2733202A1 (de) * 1976-08-04 1978-02-09 Agroferm Ag Verfahren zur herstellung der d(-)-3-hydroxybuttersaeure
US4412943A (en) * 1981-02-23 1983-11-01 Kao Soap Co., Ltd. Liquid detergent composition
FR2521857B1 (fr) * 1982-02-23 1985-10-31 Solvay Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee

Also Published As

Publication number Publication date
NZ203279A (en) 1985-04-30
DK163235B (da) 1992-02-10
DK81583D0 (da) 1983-02-23
EP0087192A1 (de) 1983-08-31
DK81583A (da) 1983-08-24
ES8500240A1 (es) 1984-10-01
IL67965A0 (en) 1983-06-15
CA1203242A (fr) 1986-04-15
NO830618L (no) 1983-08-24
NO161909B (no) 1989-07-03
AU1162483A (en) 1983-09-01
IE54561B1 (en) 1989-11-22
AU602329B2 (en) 1990-10-11
US4579955A (en) 1986-04-01
FR2521857B1 (fr) 1985-10-31
FI79523C (fi) 1990-01-10
ES532880A0 (es) 1985-07-01
AU560757B2 (en) 1987-04-16
IE830366L (en) 1983-08-23
AU6916187A (en) 1987-05-21
PH21561A (en) 1987-12-11
MX156855A (es) 1988-10-07
FI79523B (fi) 1989-09-29
PT76267A (fr) 1983-03-01
DK163235C (da) 1992-06-29
JPS58201746A (ja) 1983-11-24
US4771074A (en) 1988-09-13
KR910000143B1 (ko) 1991-01-21
DE3368601D1 (en) 1987-02-05
FI830603L (fi) 1983-08-24
ES8506283A1 (es) 1985-07-01
EP0087192B1 (de) 1986-12-30
KR840003414A (ko) 1984-09-08
NO161909C (no) 1989-10-11
FR2521857A1 (fr) 1983-08-26
FI830603A0 (fi) 1983-02-23
ES519991A0 (es) 1984-10-01
GR77934B (de) 1984-09-25
ZA831019B (en) 1983-11-30

Similar Documents

Publication Publication Date Title
ATE24478T1 (de) 3-hydroxybuttersaeure oder derer salze enthaltende pharmazeutische zusammensetzungen und als arzneimittel verwendbare, von 3hydroxybutters|ure abgeleitete verbindungen.
PT96145A (pt) Processo para a preparacao de novos derivados de aminoacidos e de composicoes farmaceuticas que os contem
IL123164A (en) Meta-guanidine urea thiourea or azacyclic amino benzoic acid derivatives and pharmaceutical compositions containing them
EA200100970A1 (ru) Аминопроизводные как ингибиторы протеазы
RU94031126A (ru) Циклические мочевины и их аналоги, пригодные в качестве ингибиторов протеазы ретровирусов, способ лечения вирусных инфекций, фармацевтическая композиция
ATE158288T1 (de) Antiatherosklerotische und antithrombotische 1- benzopyran-4-on- und 2-amino-1,3-benzoxazin-4-on- derivate
DE69431972D1 (de) HIV Protease Hemmer in pharmazeutischen Zusammensetzungen zur Behandlung von AIDS
ES8801310A1 (es) Un procedimiento para preparar derivados de alanil-protina.
DE69034226D1 (de) Herstellungsverfahren von Huperzine A und deren Analogen und Verbindungen nützlich dazu
FI941457A0 (fi) Verihiutaleglyproteiini IIb/IIIa:n inhibiittoreina käyttökelpoisia syklisiä yhdisteitä
PT97395A (pt) Processo para a preparacao de 2,9-di-substituidas-4h-pirido{1,2-a}-pirimidin-4-onas e de composicoes farmaceuticas que os contem
RU94044534A (ru) Амино-производные тиазола, способы их получения и содержащие их фармацевтические композиции
ATE84026T1 (de) Spirotricycloaromatische succinimidderivate als aldose-reduktase-inhibitoren.
AT365926B (de) Verfahren zum stabilisieren von pharmakologisch aktiven prostacyclinverbindungen
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
SE7509884L (sv) Fenyletylaminderivat
ES443599A1 (es) Un procedimiento para la preparacion de acidos 3-alquil-3- cefem-4-carboxilicos.
DK222886D0 (da) Propionylanilider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse forbindelser